Publications by authors named "Sudhir Tauro"

Claim this Profile
T
The enzyme glycogen synthase kinase-3 is associated with specific forms of oncogenesis; what more do we need to know to achieve clinical benefit?
Calum Sutherland, Ruby Harrower, Josh T Coats, Sudhir Tauro

Biochim Biophys Acta Rev Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elraglusib Induces Cytotoxicity via Direct Microtubule Destabilization Independently of GSK3 Inhibition.
Josh T Coats, Shuyu Li, Tomoyuki U Tanaka, Sudhir Tauro, Calum Sutherland

Cancer Res Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation.
Harry J Iland, Nigel Russell, Richard Dillon, Andre C Schuh, Aditya Tedjaseputra, Sudhir Tauro

Blood Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition.
Josh T Coats, Sudhir Tauro, Calum Sutherland

Cell Commun Signal· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemia.
Thomas Coats, Daniel Bean, Aymeric Basset, Tamir Sirkis, Jonathan Brammeld, Sudhir Tauro

Br J Haematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 infection in aplastic anemia.
Daniele Avenoso, Judith C W Marsh, Victoria Potter, Antonio Pagliuca, Simon Slade, Sudhir Tauro

Haematologica· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis.
Richard Dillon, Matthew J Ahearne, Lynn Quek, Nicola Potter, Jelena Jovanovic, Sudhir Tauro

Leukemia· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The long shadow of socioeconomic deprivation over the modern management of acute myeloid leukemia: time to unravel the challenges.
M Joseph John, Philip Kuriakose, Mark Smith, Eve Roman, Sudhir Tauro

Blood Cancer J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosuppression in hematological cancer patients with Covid-19 -Uncomplicated infections but delayed viral clearance?
Karen Boyd, Benjamin Parcell, Sudhir Tauro

Leuk Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.
Luca Malcovati, Kristen Stevenson, Elli Papaemmanuil, Donna Neuberg, Rafael Bejar, Sudhir Tauro

Blood· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An exemplar population-based study to predict up-take of non-intensive therapies in acute myeloid leukaemia.
Keith Ip, Khaled Bedair, Sudhir Tauro

Leuk Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups.
Detlef Haase, Kristen E Stevenson, Donna Neuberg, Jaroslaw P Maciejewski, Aziz Nazha, Sudhir Tauro

Leukemia· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythematous Macular Eruption in an Older Woman.
David McLaughlin, Neil M Kernohan, Sudhir Tauro

JAMA Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS.
Yasushi Miyazaki, Heinz Tuechler, Guillermo Sanz, Julie Schanz, Guillermo Garcia-Manero, Sudhir Tauro

Leuk Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diversity of neutrophil inclusion bodies in fulminant sepsis.
Karen Boyd, Sudhir Tauro

Br J Haematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomere length is an independent prognostic marker in MDS but not in de novo AML.
Jenna Williams, Nicole H Heppel, Bethan Britt-Compton, Julia W Grimstead, Rhiannon E Jones, Sudhir Tauro

Br J Haematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes.
Peter L Greenberg, Heinz Tuechler, Julie Schanz, Guillermo Sanz, Guillermo Garcia-Manero, Sudhir Tauro

Blood· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual extranodal T-cell non-Hodgkin lymphoma.
Josh T Coats, Alasdair D R Mackie, Neil M Kernohan, Prasad Guntur Ramkumar, Lesley M McMahon, Sudhir Tauro

Lancet· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-dependent changes in mortality and transformation risk in MDS.
Michael Pfeilstöcker, Heinz Tuechler, Guillermo Sanz, Julie Schanz, Guillermo Garcia-Manero, Sudhir Tauro

Blood· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of socioeconomic status on disease phenotype, genomic landscape and outcomes in myelodysplastic syndromes.
Francesca Mastaglio, Khaled Bedair, Elli Papaemmanuil, Michael J Groves, Ann Hyslop, Sudhir Tauro

Br J Haematol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.
Petter S Woll, Una Kjällquist, Onima Chowdhury, Helen Doolittle, David C Wedge, Sudhir Tauro

Cancer Cell· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and biological implications of driver mutations in myelodysplastic syndromes.
Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, Sudhir Tauro, Gunes Gundem

Blood· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6.
Stephanie F MacCallum, Michael J Groves, John James, Karen Murray, Virginia Appleyard, Sudhir Tauro

Sci Rep· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine-eligibility in higher-risk myelodysplastic syndromes and chronic myelomonocytic leukaemia: a registry-based study.
Senthilkumar Durairaj, Norene Keenan, Ann Hyslop, Michael J Groves, David T Bowen, Sudhir Tauro

Br J Haematol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of p53-pathway Protein Expression in Chemosensitive Chronic Lymphocytic Leukemia: A Pilot Study.
Michael J Groves, Stephanie F Maccallum, Michael T Boylan, Sally Haydock, Joan Cunningham, Sudhir Tauro

J Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis